An intraosseous device for studies of bone-healing. The effect of transforming growth-factor beta.
A novel implantable device, the analytic bone implant, was used in order to establish a model for studies of bone-healing and the evaluation of factors that augment the process, such as transforming growth-factor beta (TGF-beta). This device was implanted into the tibiae of four baboons. After healing, bone was removed from the center chamber. Recombinant human TGF beta-1 was then delivered to the core of the device. After twenty-two days of healing, the device was disassembled and the newly formed bone was removed from the core of the implant for histomorphometric analysis. An analysis of the bone revealed a substantial effect of TGF-beta on osteoblastic activity and proliferation compared with that seen in control and placebo groups. However, despite increased osteoblastic activity, trabecular bone volumes at twenty-two days were equivalent among the groups. The number of osteoclasts and the erosion of the surface were also increased, although not significantly so. Substantial endochondral formation of bone was seen in the supraperiosteal tissues directly over the implants that contained TGF-beta but not over the implants in the control and placebo groups. These data demonstrate the utility of this bone-implant model for studies of bone-healing with minimally invasive methods. In addition, use of the device provided the first in vivo data on the effects of TGF-beta at an intermediate (twenty-two-day) time-point in the healing process in a non-human primate.
Aufdemorte
T B
TB
University of Texas Health Science Center, San Antonio 78284-7750.
Fox
W C
WC
Holt
G R
GR
McGuff
H S
HS
Ammann
A J
AJ
Beck
L S
LS
D000818:Animals; D001861:Bone Regeneration / Q000187:drug effects* / Q000502:physiology; D016503:Drug Delivery Systems / Q000295:instrumentation; D008297:Male; D008954:Models, Biological; D010006:Osteoblasts / Q000166:cytology / Q000502:physiology; D010010:Osteoclasts / Q000502:physiology; D010215:Papio; D019736:Prostheses and Implants; D011994:Recombinant Proteins; D013048:Specimen Handling / Q000295:instrumentation*; D016212:Transforming Growth Factor beta / Q000008:administration & dosage* / Q000494:pharmacology
D011994:Recombinant Proteins; D016212:Transforming Growth Factor beta